Developer docs
API playgroundTry for free, no card

Search company profiles

Creative Peptides

Full company profile

uuid000b8ec

Namestring
Creative Peptides
Legal namestring
Creative Peptides
Company typeenum
Private
Founded yearint
2005
Descriptiontext

Creative Peptides is a privately held peptide Contract Development and Manufacturing Organization (CDMO) founded in 2005, headquartered in Shirley, New York, with a European office in Kriftel, Germany. The company provides custom peptide synthesis, peptide modification, custom conjugation services, cGMP-compliant peptide manufacturing, and end-to-end CDMO services spanning process development through commercial supply. Its core technology stack rests on solid-phase peptide synthesis (SPPS) with Fmoc chemistry, supporting linear, cyclic, stapled, disulfide-rich, macrocyclic, and long-chain peptides as well as non-natural amino acids and peptidomimetics, complemented by an extensive modification and conjugation portfolio covering PEGylation, lipidation, fluorophore labeling, click chemistry, bioconjugation, and peptide-oligonucleotide, peptide-polymer, peptide-carrier protein, peptide-fatty acid, peptide-imaging agent, peptide-enzyme, and nanoparticle conjugations.

Beyond chemistry services, the company has positioned four proprietary technology platforms as strategic differentiators: the IntraCellular Delivery System (ICDS™) for intracellular transport of therapeutic payloads, the Integrated Long-Acting Peptide Technology Platform, the Peptide-Oligonucleotide Conjugation (POC) Platform bridging peptide and nucleic acid therapeutics, and an AI-based Peptide Drug Discovery and Structure Analysis Platform supporting virtual screening and design optimization. It also operates a catalog business covering therapeutic peptides, cosmetic peptides, amino acids, cell-penetrating peptides, antimicrobial peptides, MHC-peptide tetramers, and PNA products, sold through an online storefront.

The business model is B2B project-based services with quote-based pricing that varies by sequence complexity, purity (70–98%+), modifications, scale (milligram research through kilogram GMP), and regulatory requirements. GMP work is contracted on multi-year supply terms while research-grade and modification services are largely pay-as-you-go. GTM is hybrid: direct enterprise field sales for CDMO and conjugation engagements, supplemented by a self-serve website channel for catalog and smaller research orders. Customers span pharmaceutical and biotechnology companies (primary), life science research organizations, and cosmetic/personal care companies, with operations and marketing reaching a global footprint via the US and German offices.

Short descriptiontext

Creative Peptides is a private peptide CDMO offering custom synthesis, modification, conjugation, and cGMP manufacturing services — from milligram research to kilogram commercial scale — to pharmaceutical, biotechnology, life science research, and cosmetic companies globally, with proprietary platforms for intracellular delivery, long-acting peptides, and AI-assisted drug discovery.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersNew York, United States
HQ citystring
New York
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
custom peptide synthesis, peptide CDMO services, cGMP peptide manufacturing, peptide conjugation services, peptide modification services
Industry3 codes
PRIMARYHLAAAAAH
Therapeutic Peptides & Protein/Peptide Biologics
Healthcare & Life Sciences/Biotechnology & Biologics/Therapeutic Biologics (mAbs, recombinant proteins, cytokines)
SECONDARYHLAAAIAL
Library & Diversity Generation Platforms (display libraries, DNA-encoded libraries for biologics, variant libraries)
Healthcare & Life Sciences/Biotechnology & Biologics/Biologic Drug Discovery Platforms (screening, antibody engineering, synthetic biology)
SECONDARYAFAJAKAG
Amino Acids & Peptides (BCAAs, Collagen Peptides, Bioactive Peptides, L-Theanine)
Agriculture & Food Production/Food Ingredients & Additives/Nutraceutical & Functional Ingredients (Vitamins, Minerals, Omega-3s, Botanicals)
NAICS code2 codes
  • Biological Product (except Diagnostic) Manufacturing325414
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code1 code
  • Biological Products, (No Disgnostic Substances)2836
Product category
Peptide Contract Development and Manufacturing (CDMO)
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model4 records
1Custom Peptide Synthesis Services
TypeProfessional Services
Description

Project-based custom peptide synthesis services ranging from milligram to kilogram scale. Pricing based on peptide length, complexity, purity requirements, and modification needs. Services include feasibility assessment, custom synthesis, and analytical validation.

creative-peptides.com
2GMP Peptide Manufacturing
TypeOne Time License
Description

GMP-compliant peptide manufacturing for clinical and commercial supply with regulatory documentation and quality systems. Long-term manufacturing partnerships and supply continuity services.

creative-peptides.com
3Peptide CDMO Services
TypeManaged Services
Description

Contract development and manufacturing organization services covering process development, scale-up, and GMP manufacturing. End-to-end support from lab to commercial scale with integrated services.

creative-peptides.com
4Catalog Peptide Products
TypeOne Time License
Description

Off-the-shelf peptide products including therapeutic peptides, cosmetic peptides, functional peptides, and high-throughput screening tools available through online ordering.

creative-peptides.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure
Pricing details3 tiers
1Research-grade peptides for R&D applications
ModelOtherBilling cadencePay-as-you-go
Notes

Quote-based pricing determined by sequence length, purity level (typically 70-98%+), modifications required, and delivery timeline

creative-peptides.com
2GMP-grade peptides for clinical and commercial use
ModelOtherBilling cadenceMulti-year contract
Notes

Higher cost reflecting GMP compliance requirements, quality documentation, regulatory support, and batch release testing

creative-peptides.com
3Custom conjugation and modification services
ModelOtherBilling cadencePay-as-you-go
Notes

Project-based pricing based on conjugation complexity, linker requirements, and analytical characterization needs

creative-peptides.com
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Creative Peptides is a peptide Contract Development and Manufacturing Organization (CDMO) that provides custom peptide synthesis, peptide modification, peptide conjugation, peptide library construction and screening, and cGMP-compliant peptide manufacturing for pharmaceutical, biotechnology, life science research, and cosmetic customers. Offerings span research-grade to GMP-grade peptides at scales from milligrams to kilograms, supported by proprietary platforms including ICDS™ intracellular delivery and AI-based peptide drug discovery.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Creative Peptides is a CDMO (Contract Development and Manufacturing Organization) specializing in high-quality peptide synthesis, modification, conjugation, and manufacturing under cGMP compliance. The company's offering is a platform-plus-modules architecture centered on core synthesis and modification services (Custom Peptide Synthesis, Peptide Modification Services, Custom Conjugation Service, cGMP Peptide Service, Peptide CDMO) supplemented by specialized platforms (IntraCellular Delivery System ICDS™, Integrated Long-Acting Peptide Technology Platform, AI-based Peptide Drug Discovery Platform, Peptide Library Construction and Screening). The product portfolio spans research-grade to GMP-grade peptides across therapeutic peptides (APIs, cyclic peptides, peptide inhibitors), cosmetic peptides (anti-aging, anti-wrinkle, hair growth), functional peptides (antimicrobial, cell-penetrating, targeting, PNA), amino acids and derivatives, and catalog peptides. Conjugation services cover nanoparticles, oligonucleotides, polymers, carrier proteins, fatty acids, imaging agents, and small molecules. The company supports drug discovery, clinical development, and cosmetic innovation through integrated end-to-end services from design through commercial-scale manufacturing.

Product and service20 records
1Custom Peptide Synthesis
CategoryCustom Peptide Synthesis
Description

Custom synthesis of peptides using solid-phase peptide synthesis (SPPS) technology, supporting linear, cyclic, stapled, and D-/L-amino acid peptides from milligram to kilogram scale; targeted at pharmaceutical, biotechnology, life science research, and cosmetic customers.

2Peptide Modification Services
CategoryPeptide Modification
Description

Comprehensive peptide modification services including glycopeptides synthesis, PNA backbone modification, N/C-terminal modifications, biotinylated peptides, PEGylation, fluorescence labeling, post-translational modifications, peptide lipidation, and cyclic peptide synthesis; for pharmaceutical, biotech, and research customers.

3Custom Conjugation Service
CategoryPeptide Conjugation
Description

Peptide conjugation services spanning peptide-drug conjugates, PEGylation, lipidation, protein coupling, peptide-oligonucleotide, peptide-antibody, and nanoparticle-peptide conjugates; for pharma, biotech, and research customers.

4cGMP Peptide Manufacturing Service
CategorycGMP Peptide Manufacturing
Description

GMP-compliant peptide manufacturing with quality systems and documentation for clinical and commercial supply; targeted at pharmaceutical and biotechnology companies.

5Peptide CDMO Services
CategoryPeptide CDMO
Description

Contract development and manufacturing organization services covering end-to-end peptide solutions from lab to commercial scale, including synthesis, process development, and GMP manufacturing; for pharmaceutical and biotechnology partners.

6Peptide Library Construction and Screening
CategoryPeptide Library & Screening
Description

Peptide library services including phage display, AI-based peptide drug discovery, animal peptide library, nanocyclic peptide library, peptide chip screening, and virtual peptide library for drug discovery applications; for pharma and biotech customers.

7Peptide Analysis Services
CategoryPeptide Analytical Services
Description

Comprehensive analytical services including biological testing, chemical/physical analyses, peptide binding affinity analysis, purity analysis, structural analysis, SPRi service, epitope mapping, peptide characterization, and amino acid analysis; for pharma, biotech, and research customers.

8Custom MHC-Peptide Tetramer Service
CategoryMHC-Peptide Tetramer Services
Description

Custom services for biotinylated pMHC monomer production, custom antigen peptide synthesis, HLA/Peptide Tetramer development, fluorescent labeling, MHC binding peptide screening, and tetramer-based antigen-specific T cell detection; for immunology research customers.

9Targeting Peptide Custom Services
CategoryTargeting Peptide Services
Description

Custom targeting peptide synthesis, design, screening, modification, conjugation, quality testing, purification, and targeted delivery system customization; for pharma, biotech, and research customers.

10IntraCellular Delivery System (ICDS™)
CategoryPeptide Delivery Platform
Description

Proprietary intracellular delivery system designed to overcome membrane barriers and enable efficient intracellular transport of peptides, proteins, and nucleic acids; offered as a technology platform to pharmaceutical and biotechnology customers.

11Integrated Long-Acting Peptide Technology Platform
CategoryLong-Acting Peptide Platform
Description

Technology platform for designing long-acting peptides using lipidation-based approaches to extend half-life and improve therapeutic profiles; offered to pharmaceutical and biotechnology customers developing peptide therapeutics.

12AI-based Peptide Drug Discovery and Structure Analysis Platform
CategoryAI Drug Discovery Platform
Description

AI-powered platform for peptide drug discovery and structural analysis supporting virtual screening, design optimization, and predictive modeling for therapeutic peptide candidates; offered to pharma and biotech customers.

13Cosmetic Peptides
CategoryCosmetic Peptide Catalog
Description

Catalog peptides for cosmetic applications including anti-aging, anti-pigmentation, anti-wrinkle, eye care, and hair growth formulations; for cosmetic and personal care companies.

14Therapeutic Peptides
CategoryTherapeutic Peptide Catalog
Description

Catalog therapeutic peptide products including APIs, cyclic peptides, peptide inhibitors, and tumor antigen-derived peptides for pharmaceutical research.

15Amino Acids
CategoryAmino Acid Catalog
Description

Catalog amino acid products including standard amino acids and derivatives, glycosylated amino acids, protected amino acids, stable isotope labeled amino acids, and other specialty amino acids.

16Cell Penetrating Peptides
CategoryCell Penetrating Peptide Catalog
Description

Catalog cell-penetrating peptides designed to facilitate cellular uptake and membrane translocation of biologically active molecules; for research and drug delivery applications.

17Antimicrobial Peptides
CategoryAntimicrobial Peptide Catalog
Description

Catalog host defense peptides (5-40 amino acids) with natural antibiotic properties for research and therapeutic development.

18Peptide Nucleic Acid (PNA)
CategoryPNA Catalog
Description

Catalog synthetic PNA analogs with peptide-like backbones offering high binding affinity and chemical stability for gene-targeting and diagnostics.

19Peptide Inhibitors
CategoryPeptide Inhibitor Catalog
Description

Catalog peptide-based inhibitors with high affinity and specificity used in drug discovery and research applications.

20MHC-Peptide Tetramer
CategoryMHC-Peptide Tetramer Catalog
Description

Catalog MHC-Peptide Tetramer complexes formed by binding four copies of a specific peptide with MHC molecules for T cell detection and immunology research.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierSupportingTypeOthers
Description

Partner laboratories provide optional biological evaluation and functional testing support including cellular uptake studies, gene silencing efficiency assays, nuclease resistance testing, and in vivo biodistribution studies to complement chemical conjugation services.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Global leader in peptide CDMO services and APIs, including custom synthesis, GMP manufacturing, and oligonucleotide peptide conjugates. Directly comparable to Creative Peptides across nearly the full service stack, but at substantially larger scale.

TypeDirect peer
Description

Specialty CDMO focused on custom peptide and oligonucleotide manufacturing for pharma and biotech. Closely comparable in service portfolio, with established GMP capacity and a broader customer base than Creative Peptides.

TypeDirect peer
Description

Offers custom peptide synthesis, gene synthesis, and protein services through its life-science CDMO arm. Overlaps significantly with Creative Peptides' research-grade and GMP peptide offerings and serves a similar biotech customer base.

TypeDirect peer
Description

Peptide-focused CDMO providing custom synthesis, GMP manufacturing, and peptide modification services. A close head-to-head competitor in custom and GMP peptide services, particularly in the US market.

TypeDirect peer
Description

Peptide synthesis and GMP manufacturing CDMO with peptide synthesizer manufacturing. Competes with Creative Peptides in custom peptide production and contract manufacturing.

TypeDirect peer
Description

Provider of custom peptides, antibodies, and biochemical reagents with GMP capabilities. Overlaps with Creative Peptides in custom peptide synthesis, modifications, and labeling services for research customers.

7AAPPTec
TypeEmerging player
Description

Specializes in peptide synthesis reagents, resins, and custom peptide services with a research-grade focus. Comparable to Creative Peptides' catalog and research-grade peptide offerings, though smaller in GMP scope.

TypeBroad incumbent
Description

Global CDMO with peptide, oligonucleotide, and bioconjugate manufacturing capabilities across mammalian and chemical synthesis. Competes with Creative Peptides in GMP peptide and peptide-oligonucleotide services but as part of a much broader portfolio.

TypeBroad incumbent
Description

Large CDMO offering peptide API manufacturing and related services among its broader small-molecule and biologics portfolio. Comparable in CDMO positioning but at significantly greater scale and breadth.

TypeBroad incumbent
Description

Global CRO/CDMO with growing peptide and bioconjugate manufacturing capabilities. Represents the scale-driven competitive threat Creative Peptides faces in winning large pharma outsourcing contracts.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Creative Peptides

Peptide Contract Development and Manufacturing (CDMO)creative-peptides.com

Creative Peptides is a private peptide CDMO offering custom synthesis, modification, conjugation, and cGMP manufacturing services — from milligram research to kilogram commercial scale — to pharmaceutical, biotechnology, life science research, and cosmetic companies globally, with proprietary platforms for intracellular delivery, long-acting peptides, and AI-assisted drug discovery.

What Creative Peptides does

Creative Peptides is a privately held peptide Contract Development and Manufacturing Organization (CDMO) founded in 2005, headquartered in Shirley, New York, with a European office in Kriftel, Germany. The company provides custom peptide synthesis, peptide modification, custom conjugation services, cGMP-compliant peptide manufacturing, and end-to-end CDMO services spanning process development through commercial supply. Its core technology stack rests on solid-phase peptide synthesis (SPPS) with Fmoc chemistry, supporting linear, cyclic, stapled, disulfide-rich, macrocyclic, and long-chain peptides as well as non-natural amino acids and peptidomimetics, complemented by an extensive modification and conjugation portfolio covering PEGylation, lipidation, fluorophore labeling, click chemistry, bioconjugation, and peptide-oligonucleotide, peptide-polymer, peptide-carrier protein, peptide-fatty acid, peptide-imaging agent, peptide-enzyme, and nanoparticle conjugations.

Beyond chemistry services, the company has positioned four proprietary technology platforms as strategic differentiators: the IntraCellular Delivery System (ICDS™) for intracellular transport of therapeutic payloads, the Integrated Long-Acting Peptide Technology Platform, the Peptide-Oligonucleotide Conjugation (POC) Platform bridging peptide and nucleic acid therapeutics, and an AI-based Peptide Drug Discovery and Structure Analysis Platform supporting virtual screening and design optimization. It also operates a catalog business covering therapeutic peptides, cosmetic peptides, amino acids, cell-penetrating peptides, antimicrobial peptides, MHC-peptide tetramers, and PNA products, sold through an online storefront.

The business model is B2B project-based services with quote-based pricing that varies by sequence complexity, purity (70–98%+), modifications, scale (milligram research through kilogram GMP), and regulatory requirements. GMP work is contracted on multi-year supply terms while research-grade and modification services are largely pay-as-you-go. GTM is hybrid: direct enterprise field sales for CDMO and conjugation engagements, supplemented by a self-serve website channel for catalog and smaller research orders. Customers span pharmaceutical and biotechnology companies (primary), life science research organizations, and cosmetic/personal care companies, with operations and marketing reaching a global footprint via the US and German offices.

Creative Peptides firmographics

Firmographics
Name
Creative Peptides
Legal name
Creative Peptides
Website
https://creative-peptides.com
Company type
Private
Founded year
2005
Operating status
Operating
Headcount range
1–10 employees
Short description
Creative Peptides is a private peptide CDMO offering custom synthesis, modification, conjugation, and cGMP manufacturing services — from milligram research to kilogram commercial scale — to pharmaceutical, biotechnology, life science research, and cosmetic companies globally, with proprietary platforms for intracellular delivery, long-acting peptides, and AI-assisted drug discovery.
Ownership category
akta.pro rank

Creative Peptides industry classification

Industry
Product category
Peptide Contract Development and Manufacturing (CDMO)
NAICS
Biological Product (except Diagnostic) Manufacturing (325414), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Biological Products, (No Disgnostic Substances) (2836)
akta.pro industry
PRIMARYHLAAAAAH
Therapeutic Peptides & Protein/Peptide Biologics
Healthcare & Life Sciences/Biotechnology & Biologics/Therapeutic Biologics (mAbs, recombinant proteins, cytokines)
SECONDARYHLAAAIAL
Library & Diversity Generation Platforms (display libraries, DNA-encoded libraries for biologics, variant libraries)
Healthcare & Life Sciences/Biotechnology & Biologics/Biologic Drug Discovery Platforms (screening, antibody engineering, synthetic biology)
SECONDARYAFAJAKAG
Amino Acids & Peptides (BCAAs, Collagen Peptides, Bioactive Peptides, L-Theanine)
Agriculture & Food Production/Food Ingredients & Additives/Nutraceutical & Functional Ingredients (Vitamins, Minerals, Omega-3s, Botanicals)

Keywords

  • Custom peptide synthesis
  • Peptide CDMO services
  • CGMP peptide manufacturing
  • Peptide conjugation services
  • Peptide modification services

Where Creative Peptides is headquartered

Location

Headquarters

HQ city
New York
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Creative Peptides business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

  1. Custom Peptide Synthesis Services: Project-based custom peptide synthesis services ranging from milligram to kilogram scale. Pricing based on peptide length, complexity, purity requirements, and modification needs. Services include feasibility assessment, custom synthesis, and analytical validation.
  2. GMP Peptide Manufacturing: GMP-compliant peptide manufacturing for clinical and commercial supply with regulatory documentation and quality systems. Long-term manufacturing partnerships and supply continuity services.
  3. Peptide CDMO Services: Contract development and manufacturing organization services covering process development, scale-up, and GMP manufacturing. End-to-end support from lab to commercial scale with integrated services.
  4. Catalog Peptide Products: Off-the-shelf peptide products including therapeutic peptides, cosmetic peptides, functional peptides, and high-throughput screening tools available through online ordering.

Pricing tiers

ModelBillingPrice
OtherPay-as-you-goResearch-grade peptides for R&D applications
OtherMulti-year contractGMP-grade peptides for clinical and commercial use
OtherPay-as-you-goCustom conjugation and modification services

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Creative Peptides product offering

Product offering

Core offering

Creative Peptides is a peptide Contract Development and Manufacturing Organization (CDMO) that provides custom peptide synthesis, peptide modification, peptide conjugation, peptide library construction and screening, and cGMP-compliant peptide manufacturing for pharmaceutical, biotechnology, life science research, and cosmetic customers. Offerings span research-grade to GMP-grade peptides at scales from milligrams to kilograms, supported by proprietary platforms including ICDS™ intracellular delivery and AI-based peptide drug discovery.

Product overview

Creative Peptides is a CDMO (Contract Development and Manufacturing Organization) specializing in high-quality peptide synthesis, modification, conjugation, and manufacturing under cGMP compliance. The company's offering is a platform-plus-modules architecture centered on core synthesis and modification services (Custom Peptide Synthesis, Peptide Modification Services, Custom Conjugation Service, cGMP Peptide Service, Peptide CDMO) supplemented by specialized platforms (IntraCellular Delivery System ICDS™, Integrated Long-Acting Peptide Technology Platform, AI-based Peptide Drug Discovery Platform, Peptide Library Construction and Screening). The product portfolio spans research-grade to GMP-grade peptides across therapeutic peptides (APIs, cyclic peptides, peptide inhibitors), cosmetic peptides (anti-aging, anti-wrinkle, hair growth), functional peptides (antimicrobial, cell-penetrating, targeting, PNA), amino acids and derivatives, and catalog peptides. Conjugation services cover nanoparticles, oligonucleotides, polymers, carrier proteins, fatty acids, imaging agents, and small molecules. The company supports drug discovery, clinical development, and cosmetic innovation through integrated end-to-end services from design through commercial-scale manufacturing.

Differentiator

Problem solved

Functional benefit

Products and services

  • Custom Peptide Synthesis Custom synthesis of peptides using solid-phase peptide synthesis (SPPS) technology, supporting linear, cyclic, stapled, and D-/L-amino acid peptides from milligram to kilogram scale; targeted at pharmaceutical, biotechnology, life science research, and cosmetic customers.
  • Peptide Modification Services Comprehensive peptide modification services including glycopeptides synthesis, PNA backbone modification, N/C-terminal modifications, biotinylated peptides, PEGylation, fluorescence labeling, post-translational modifications, peptide lipidation, and cyclic peptide synthesis; for pharmaceutical, biotech, and research customers.
  • Custom Conjugation Service Peptide conjugation services spanning peptide-drug conjugates, PEGylation, lipidation, protein coupling, peptide-oligonucleotide, peptide-antibody, and nanoparticle-peptide conjugates; for pharma, biotech, and research customers.
  • cGMP Peptide Manufacturing Service GMP-compliant peptide manufacturing with quality systems and documentation for clinical and commercial supply; targeted at pharmaceutical and biotechnology companies.
  • Peptide CDMO Services Contract development and manufacturing organization services covering end-to-end peptide solutions from lab to commercial scale, including synthesis, process development, and GMP manufacturing; for pharmaceutical and biotechnology partners.
  • Peptide Library Construction and Screening Peptide library services including phage display, AI-based peptide drug discovery, animal peptide library, nanocyclic peptide library, peptide chip screening, and virtual peptide library for drug discovery applications; for pharma and biotech customers.
  • Peptide Analysis Services Comprehensive analytical services including biological testing, chemical/physical analyses, peptide binding affinity analysis, purity analysis, structural analysis, SPRi service, epitope mapping, peptide characterization, and amino acid analysis; for pharma, biotech, and research customers.
  • Custom MHC-Peptide Tetramer Service Custom services for biotinylated pMHC monomer production, custom antigen peptide synthesis, HLA/Peptide Tetramer development, fluorescent labeling, MHC binding peptide screening, and tetramer-based antigen-specific T cell detection; for immunology research customers.
  • Targeting Peptide Custom Services Custom targeting peptide synthesis, design, screening, modification, conjugation, quality testing, purification, and targeted delivery system customization; for pharma, biotech, and research customers.
  • IntraCellular Delivery System (ICDS™) Proprietary intracellular delivery system designed to overcome membrane barriers and enable efficient intracellular transport of peptides, proteins, and nucleic acids; offered as a technology platform to pharmaceutical and biotechnology customers.
  • Integrated Long-Acting Peptide Technology Platform Technology platform for designing long-acting peptides using lipidation-based approaches to extend half-life and improve therapeutic profiles; offered to pharmaceutical and biotechnology customers developing peptide therapeutics.
  • AI-based Peptide Drug Discovery and Structure Analysis Platform AI-powered platform for peptide drug discovery and structural analysis supporting virtual screening, design optimization, and predictive modeling for therapeutic peptide candidates; offered to pharma and biotech customers.
  • Cosmetic Peptides Catalog peptides for cosmetic applications including anti-aging, anti-pigmentation, anti-wrinkle, eye care, and hair growth formulations; for cosmetic and personal care companies.
  • Therapeutic Peptides Catalog therapeutic peptide products including APIs, cyclic peptides, peptide inhibitors, and tumor antigen-derived peptides for pharmaceutical research.
  • Amino Acids Catalog amino acid products including standard amino acids and derivatives, glycosylated amino acids, protected amino acids, stable isotope labeled amino acids, and other specialty amino acids.
  • Cell Penetrating Peptides Catalog cell-penetrating peptides designed to facilitate cellular uptake and membrane translocation of biologically active molecules; for research and drug delivery applications.
  • Antimicrobial Peptides Catalog host defense peptides (5-40 amino acids) with natural antibiotic properties for research and therapeutic development.
  • Peptide Nucleic Acid (PNA) Catalog synthetic PNA analogs with peptide-like backbones offering high binding affinity and chemical stability for gene-targeting and diagnostics.
  • Peptide Inhibitors Catalog peptide-based inhibitors with high affinity and specificity used in drug discovery and research applications.
  • MHC-Peptide Tetramer Catalog MHC-Peptide Tetramer complexes formed by binding four copies of a specific peptide with MHC molecules for T cell detection and immunology research.

Companies that use Creative Peptides

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Creative Peptides technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature6 records

Creative Peptides partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Qualified Partner LaboratoriessupportingOthersPartner laboratories provide optional biological evaluation and functional testing support including cellular uptake studies, gene silencing efficiency assays, nuclease resistance testing, and in vivo biodistribution studies to complement chemical conjugation services.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Creative Peptides competitors and assessment

Company assessment

Direct peers

  • Bachem: Global leader in peptide CDMO services and APIs, including custom synthesis, GMP manufacturing, and oligonucleotide peptide conjugates. Directly comparable to Creative Peptides across nearly the full service stack, but at substantially larger scale.
  • PolyPeptide Group: Specialty CDMO focused on custom peptide and oligonucleotide manufacturing for pharma and biotech. Closely comparable in service portfolio, with established GMP capacity and a broader customer base than Creative Peptides.
  • GenScript: Offers custom peptide synthesis, gene synthesis, and protein services through its life-science CDMO arm. Overlaps significantly with Creative Peptides' research-grade and GMP peptide offerings and serves a similar biotech customer base.
  • CPC Scientific: Peptide-focused CDMO providing custom synthesis, GMP manufacturing, and peptide modification services. A close head-to-head competitor in custom and GMP peptide services, particularly in the US market.
  • CSBio: Peptide synthesis and GMP manufacturing CDMO with peptide synthesizer manufacturing. Competes with Creative Peptides in custom peptide production and contract manufacturing.
  • AnaSpec (Eurogentec): Provider of custom peptides, antibodies, and biochemical reagents with GMP capabilities. Overlaps with Creative Peptides in custom peptide synthesis, modifications, and labeling services for research customers.

Emerging players

  • AAPPTec: Specializes in peptide synthesis reagents, resins, and custom peptide services with a research-grade focus. Comparable to Creative Peptides' catalog and research-grade peptide offerings, though smaller in GMP scope.

Broad incumbents

  • Lonza: Global CDMO with peptide, oligonucleotide, and bioconjugate manufacturing capabilities across mammalian and chemical synthesis. Competes with Creative Peptides in GMP peptide and peptide-oligonucleotide services but as part of a much broader portfolio.
  • Curia (formerly AMRI): Large CDMO offering peptide API manufacturing and related services among its broader small-molecule and biologics portfolio. Comparable in CDMO positioning but at significantly greater scale and breadth.
  • WuXi AppTec / WuXi Biologics: Global CRO/CDMO with growing peptide and bioconjugate manufacturing capabilities. Represents the scale-driven competitive threat Creative Peptides faces in winning large pharma outsourcing contracts.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Creative Peptides social profiles

Digital presence

Creative Peptides financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Creative Peptides leadership team

Management profile

Number of profiles

Creative Peptides funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Creative Peptides M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Creative Peptides

What does Creative Peptides do?

Creative Peptides is a peptide Contract Development and Manufacturing Organization (CDMO) that provides custom peptide synthesis, peptide modification, peptide conjugation, peptide library construction and screening, and cGMP-compliant peptide manufacturing for pharmaceutical, biotechnology, life science research, and cosmetic customers. Offerings span research-grade to GMP-grade peptides at scales from milligrams to kilograms, supported by proprietary platforms including ICDS™ intracellular delivery and AI-based peptide drug discovery.

Is Creative Peptides a public or private company?

Creative Peptides is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Creative Peptides founded?

Creative Peptides was founded in 2005. It employs 1 to 10 people.

Where is Creative Peptides based?

Creative Peptides is headquartered in New York, United States, in the North America region.

How does Creative Peptides make money?

Four revenue lines are on record. Custom Peptide Synthesis Services are the primary driver. The others are GMP Peptide Manufacturing, peptide CDMO Services and catalog Peptide Products.

Who are Creative Peptides's main competitors?

Direct peers on record are Bachem, PolyPeptide Group, GenScript, CPC Scientific, CSBio and AnaSpec (Eurogentec). AAPPTec is listed as an emerging player. Broad incumbents are Lonza, Curia (formerly AMRI) and WuXi AppTec / WuXi Biologics.

Does Creative Peptides have an API?

No public API is recorded for Creative Peptides.

What industry is Creative Peptides in?

Creative Peptides's product category is Peptide Contract Development and Manufacturing (CDMO). Its primary akta.pro industry code is HLAAAAAH, Therapeutic Peptides & Protein/Peptide Biologics, with a secondary code of HLAAAIAL, Library & Diversity Generation Platforms (display libraries, DNA-encoded libraries for biologics, variant libraries). Its NAICS code is 325414 and its SIC code is 2836.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals